Literature DB >> 16330618

Why the Hamilton Depression Rating Scale endures.

Per Bech, Nina Engelhardt, Kenneth R Evans, Michael Gibertini, Amir H Kalali, Kenneth A Kobak, Joshua D Lipsitz, Janet B W Williams, Jay D Pearson, Margaret Rothman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330618     DOI： 10.1176/appi.ajp.162.12.2396

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  2 in total

1.  Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.

Authors:  Daniela Silva Moura; Serge Sultan; Sophie Georgin-Lavialle; Nathalie Pillet; François Montestruc; Paul Gineste; Stéphane Barete; Gandhi Damaj; Alain Moussy; Olivier Lortholary; Olivier Hermine
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

2.  Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study.

Authors:  Jitsuki Sawamura; Jun Ishigooka; Katsuji Nishimura
Journal:  Health Qual Life Outcomes       Date:  2018-01-16       Impact factor: 3.186
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.